Kinemucil

Acetylcysteine, the active ingredient in Kinemucil, is a mucolytic agent presented as an oral formulation for oral use. It reduces the viscosity of respiratory secretions and is employed in the management of chronic bronchitis, COPD, asthma and sinusitis to facilitate mucus clearance. GNH USA supplies Kinemucil as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Kinemucil, a mucolytic drug, acts on the respiratory tract to improve clearance of thickened secretions. - Chronic bronchitis: helps loosen and clear mucus, easing cough and breathing. - Chronic obstructive pulmonary disease (COPD): reduces sputum viscosity, supporting airway patency. - Asthma: assists in clearing mucus plugs that can exacerbate airway obstruction. - Sinusitis: facilitates drainage of thick sinus secretions, relieving congestion.

Acetylcysteine may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Vomiting: occasional expulsion of stomach contents. - Diarrhea: loose stools occurring after ingestion. - Abdominal discomfort: cramping or pain in the stomach area.

Serious or Rare Side Effects: - Anaphylactic reaction: severe allergic response requiring immediate medical attention. - Bronchospasm: sudden narrowing of the airways, especially in asthmatic patients. - Hepatotoxicity: rare liver enzyme elevations indicating potential liver stress.

When using Kinemucil, consider the following safety measures. - Pregnancy: consult a healthcare professional before use; data are limited. - Breastfeeding: discuss potential risks with a physician, as the drug may pass into milk. - Renal impairment: dose adjustment may be required in patients with reduced kidney function. - Concomitant respiratory disease: monitor closely for bronchospasm in asthma. - Store at ambient temperature: keep below 25°C in the original container, protect from moisture and direct sunlight.

Acetylcysteine can affect the activity of several other medicines.

Major Interactions (Avoid): - Nitroglycerin: may enhance hypotensive effects. - Activated charcoal: can reduce acetylcysteine absorption if given simultaneously.

Moderate Interactions (Monitor Closely): - Anticoagulants (e.g., warfarin): may increase bleeding risk. - Antiplatelet agents (e.g., aspirin): monitor for enhanced anticoagulation. - Certain antibiotics (e.g., carbapenems): may interfere with mucolytic efficacy.